Explore All Access
Check if your research matches the topics covered in CANCER & METABOLISM?
- Degree of match
- Common matching concepts
- Additional journal recommendations
CANCER & METABOLISM : Impact Factor & More
eISSN: 2049-3002pISSN: 2049-3002
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
CANCER & METABOLISM Key Metrics
Eigenfactor 
0.001 - 0.005
Impact Factor
5 - 10
Topics Covered on CANCER & METABOLISM
Breast cancer
Glycolysis
Fatty acid metabolism
Immune system
Breast cancer cells
Pyruvate carboxylase
Glutamine
Metformin
Metabolic syndrome
Metabolic tumor volume
Fructose
Pyruvate carboxylase activity
Metabolomics
Tumor growth
Gene expression
Fructose metabolism
Cancer metabolism
Lipopolysaccharide
Amino acid
Glucose uptake
CANCER & METABOLISM Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2390 | USD 2790 | GBP 2090 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in CANCER & METABOLISM ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CANCER & METABOLISM
TDO2 inhibition counters Benzo[a]pyrene-induced immune evasion and suppresses tumorigenesis in lung adenocarcinoma
- 26 Nov 2024
- Cancer & Metabolism
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastoma
- 19 Nov 2024
- Cancer & Metabolism
Complete inhibition of liver acetyl-CoA carboxylase activity is required to exacerbate liver tumorigenesis in mice treated with diethylnitrosamine
- 13 Nov 2024
- Cancer & Metabolism
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function
- 28 Oct 2024
- Cancer & Metabolism
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation
- 26 Oct 2024
- Cancer & Metabolism
RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial–mesenchymal transition
- 26 Oct 2024
- Cancer & Metabolism
TDO2 inhibition counters Benzo[a]pyrene-induced immune evasion and suppresses tumorigenesis in lung adenocarcinoma
- 26 Nov 2024
- Cancer & Metabolism
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastoma
- 19 Nov 2024
- Cancer & Metabolism
Complete inhibition of liver acetyl-CoA carboxylase activity is required to exacerbate liver tumorigenesis in mice treated with diethylnitrosamine
- 13 Nov 2024
- Cancer & Metabolism
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function
- 28 Oct 2024
- Cancer & Metabolism
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation
- 26 Oct 2024
- Cancer & Metabolism
RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial–mesenchymal transition
- 26 Oct 2024
- Cancer & Metabolism
Compare Similar Journals with CANCER & METABOLISM
Select Journals to Compare with CANCER & METABOLISM
Total journals - 9
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
International Journal of Molecular Sciences
Publisher: MDPI
Cancers
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Oncotarget
Publisher: Impact Journals
Scientific Reports
Publisher: NATURE PORTFOLIO
Cell Death and Disease
Publisher: SPRINGERNATURE
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Life Sciences
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
0 Journals Selected to compare with
CANCER & METABOLISM
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on CANCER & METABOLISM
How long has CANCER & METABOLISM been actively publishing? 
CANCER & METABOLISM has been in operation since 2013 till date.
What is the publishing frequency of CANCER & METABOLISM?
CANCER & METABOLISM published with a Continuous publication frequency.
How many articles did CANCER & METABOLISM publish last year?
In 2023, CANCER & METABOLISM publsihed 27 articles.
What is the eISSN & pISSN for CANCER & METABOLISM?
For CANCER & METABOLISM, eISSN is 2049-3002 and pISSN is 2049-3002.
Who is the publisher of CANCER & METABOLISM?
BMC is the publisher of CANCER & METABOLISM.
